Geoffrey Beran Rose
2022
In 2022, Geoffrey Beran Rose earned a total compensation of $2.2M as Chief Commercial Officer at Pulmonx Corp, a 8% increase compared to previous year.
Compensation breakdown
| Bonus | $94,951 |
|---|---|
| Non-Equity Incentive Plan | $46,912 |
| Option Awards | $809,424 |
| Salary | $417,000 |
| Stock Awards | $823,360 |
| Other | $1,416 |
| Total | $2,193,063 |
Rose received $823.4K in stock awards, accounting for 38% of the total pay in 2022.
Rose also received $95K in bonus, $46.9K in non-equity incentive plan, $809.4K in option awards, $417K in salary and $1.4K in other compensation.
Rankings
In 2022, Geoffrey Beran Rose's compensation ranked 1,636th out of 5,736 executives tracked by ExecPay. In other words, Rose earned more than 71.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,636 out of 5,736 | 72nd |
Division Manufacturing | 844 out of 3,125 | 73rd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 108 out of 485 | 78th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 71 out of 347 | 80th |
Industry Surgical and Medical Instruments and Apparatus | 59 out of 253 | 77th |
Source: SEC filing on April 4, 2023.
Rose's colleagues
We found two more compensation records of executives who worked with Geoffrey Beran Rose at Pulmonx Corp in 2022.